These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 228185)
41. The global impact of hepatic fibrosis and end-stage liver disease. Lim YS; Kim WR Clin Liver Dis; 2008 Nov; 12(4):733-46, vii. PubMed ID: 18984463 [TBL] [Abstract][Full Text] [Related]
48. Nonalcoholic fatty liver in a developing country is responsible for significant liver disease. Duseja A; Sharma B; Kumar A; Kapil S; Das A; Dhiman RK; Chawla YK Hepatology; 2010 Dec; 52(6):2248-9. PubMed ID: 20725907 [No Abstract] [Full Text] [Related]
49. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis. Iwamura K Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271 [TBL] [Abstract][Full Text] [Related]
50. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease. Ong JP; Younossi ZM Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567 [TBL] [Abstract][Full Text] [Related]
51. Hepatocellular carcinoma following neonatal hepatitis. Moore L; Bourne AJ; Moore DJ; Preston H; Byard RW Pediatr Pathol Lab Med; 1997; 17(4):601-10. PubMed ID: 9211553 [TBL] [Abstract][Full Text] [Related]
52. Efforts to define the natural history of chronic hepatitis C continue. Ghany MG; Seeff LB Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1190-2. PubMed ID: 17045209 [No Abstract] [Full Text] [Related]
53. [The liver of the severely obese patient treated with a jejuno-ileal shunt. Functional and morphological aspects]. Scopinaro N; Badini A; Gianetta E; Bonalumi U Minerva Chir; 1976 May; 31(10):577-86. PubMed ID: 972734 [No Abstract] [Full Text] [Related]
54. [Condition of the liver and biliary tract in diabetes mellitus]. Mosin VI Klin Med (Mosk); 1974 Jul; 52(7):18-24. PubMed ID: 4603427 [No Abstract] [Full Text] [Related]
55. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease]. Sata M; Tokeshi S; Nakano H; Majima Y; Tanikawa K Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247 [TBL] [Abstract][Full Text] [Related]
56. Nutritional deficiencies in liver disease. Leevy CM; Baker H Med Clin North Am; 1970 Mar; 54(2):467-77. PubMed ID: 4313491 [No Abstract] [Full Text] [Related]
57. [Liver lesions due to gastroduodenal ulcer or gastric surgery?]. Schriefers KH; Luchmann A; Hardt U Bruns Beitr Klin Chir (1971); 1973 Apr; 220(2):144-50. PubMed ID: 4701080 [No Abstract] [Full Text] [Related]
58. The pathological spectrum of alcoholic liver disease. Hall PD Pathology; 1985 Apr; 17(2):209-18. PubMed ID: 2995905 [No Abstract] [Full Text] [Related]
59. NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes. Bugianesi E; Vanni E; Marchesini G Curr Diab Rep; 2007 Jun; 7(3):175-80. PubMed ID: 17547834 [TBL] [Abstract][Full Text] [Related]
60. Diabetes and the hepatobiliary system. Farrell FJ; Keeffe EB Clin Liver Dis; 1998 Feb; 2(1):119-31, vii. PubMed ID: 15560049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]